Companies /Healthcare

Airsculpt Technologies Inc

NASDAQ: AIRS Medical Care Facilities
$0.70
▼ $0.14 (−16.37%) today
Markets closed · 9:57pm ET

AIRS at a Glance

Valuation
Market cap
$61.9M
Profitability
Revenue (TTM)
$147.7M
Profit margin
-6.4%
EPS (TTM)
$-0.12
Price
52-week range
$1 – $6
Street target
$1.50

Headquartered in Tampa, FL Fiscal year ends December NASDAQ: AIRS airsculpt.com

About Airsculpt Technologies

AirSculpt Technologies, Inc. (NASDAQ: AIRS) is a U.S. national provider of premium body contouring procedures, performed exclusively at its own AirSculpt offices. Its signature AirSculpt procedure is minimally invasive: it removes fat and tightens skin while sculpting targeted areas of the body, with quick healing and minimal bruising. The company earns revenue per case on elective, consumer-paid procedures. As of September 30, 2026, it operated 31 facilities with 65 procedure rooms. It is expanding GLP-1-related procedures aimed at patients who have lost weight using weight-loss drugs; these made up about 10% of third-quarter 2026 cases. It competes for patients in the broader weight-loss and obesity solutions market and for surgeons. In November 2026 the company refinanced its debt with a Blue Torch-led senior secured facility maturing in 2031, and it has used an at-the-market equity program to strengthen liquidity. Updated

Latest Activity

AIRSAirsculpt Technologies
Q3 2026
EPS
-$0.08
est -$0.03-$0.05
Revenue
$32M
est $35M-7.5%

Management cut full-year revenue guidance to $144 million to $146 million from $151 million to $157 million, assuming the 9.6% same-store case volume decline holds through year-end. Adjusted EBITDA shrank to $393,000, leaving almost no cushion.

Quarterly EPS — reported vs estimate

AIRS Coverage

Frequently Asked Questions

What does Airsculpt Technologies do?

AirSculpt Technologies, Inc. (NASDAQ: AIRS) is a U.S. national provider of premium body contouring procedures, performed exclusively at its own AirSculpt offices.

What is the AIRS stock price target?

The Wall Street consensus 12-month price target for AIRS is $1.50.